Commentary: Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications.

Abdelhakim Salem, Tuula Salo
Author Information
  1. Abdelhakim Salem: Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, Helsinki, Finland.
  2. Tuula Salo: Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, Helsinki, Finland.

Abstract

No abstract text available.

Keywords

References

  1. J Invest Dermatol. 2004 Jul;123(1):116-23 [PMID: 15191551]
  2. Br J Dermatol. 2017 May;176(5):1213-1223 [PMID: 27542662]
  3. Cell Oncol (Dordr). 2017 Dec;40(6):621-630 [PMID: 28653289]
  4. Br J Pharmacol. 2020 Feb;177(3):469-489 [PMID: 30341770]
  5. Oral Dis. 2015 Apr;21(3):378-85 [PMID: 25207698]
  6. Br J Pharmacol. 2020 Feb;177(3):516-538 [PMID: 30414378]
  7. Cancer Manag Res. 2018 Oct 12;10:4523-4535 [PMID: 30349385]
  8. Front Pharmacol. 2019 Jun 05;10:556 [PMID: 31231212]
  9. Br J Pharmacol. 2013 Sep;170(1):188-99 [PMID: 23425150]

Word Cloud

Created with Highcharts 10.0.0HistamineH4OralcancerCommentary:PathophysiologicalRoleReceptorCancer:TherapeuticImplicationsreceptorCancerOCtongueheadneck

Similar Articles

Cited By

No available data.